ARENA: GOOD TRIAL RESULTS FROM THIS BIOTECH, OVER 400% GAIN POSSIBLE IN A BUYOUT $ARNA

ARENA: GOOD TRIAL RESULTS FROM THIS BIOTECH, OVER 400% GAIN POSSIBLE IN A BUYOUT $ARNA

This post was just published on ZYX Buy Change Alert.

 Arena stock (ARNA) is long from $16.20.  ARNA is trading at $40.75 as of this writing, up $9.86 for the day.  It has traded as high as $44.44.

The company reported impressive results from a Phase II trial of its ulcerative colitis drug.

Previously we have stated that in a buyout,

In the event of a buyout, a price in the zone of $44 to $52 is possible.

Based on the trial results, we are revising the target zone in a buyout to $75 to $88.

The new buy zone for Arena is $28 to $35.57. Buy zones are designed for a 70% probability of a fill in the next 120 days.  Remember that biotechs are very volatile and in the event of a correction in biotechs, the stock can easily trade in the buy zone.  The ‘Buy Now’ rating is a ‘NO’.

What To Do Now

Those in the stock who have been booking some profits along the way in their portfolio and can afford additional risk may continue to hold.

Those in the stock and have not been booking profits in their portfolio or do not want to take additional risk may consider taking partial profits.

Caution: Biotechs are very volatile. There is no guarantee that Phase III trial will be successful.  In the event of a trial failure, biotech stocks can fall dramatically.

A knowledgeable investor would have turned $100,000 into over $1,000,000 with the help from The Arora Report. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Check out our enviable performance in both bull and bear markets.

FREE: SUBSCRIBE TO ‘GENERATE WEALTH’ NEWSLETTER

Related Posts

NEW BUY ZONE ON ARENA FOR THOSE NOT IN IT AND NEW TARGETS $ARNA

This post was just published on ZYX Buy Change Alert.  New buy zone for those not in ARNA is $20.33 to $22.78.  Maximum ...

NICE GAINS ON ARENA AS IT JUMPS 25% ON POSITIVE DRUG RESULTS, GAINS NOT AS BIG AS SOME ARE MISTAKENLY THINKING $ARNA

This post was published on ZYX Buy Change Alert.   ARNA is long from $16.20.  It is trading at $25 as of this writing.  ...

USE THE JANUARY EFFECT FOR A POTENTIAL 30% RETURN $AA $APA $BTU $FCX $X $ARNA $M $JWN $OREX $NVAX $ASNA $CHS $GPS $EVDY $ARNA

The January Effect offers an opportunity to potentially make about 30% in three months. It is a phenomenon that makes ...

ARENA OBESITY DRUG APPROVAL MAY SIGNAL FDA OPENING UP FAT PILL FLOODGATES

The U.S. Food and Drug Administration (FDA) has approved the first obesity drug in 15 years. The drug is lorcaserin, ...

NEW IDEA ON OREXIGEN THERAPUTICS (OREX)

This post was  published earlier on ZYX BuyChange Alert OREX is a sympathy play with ARNA. FDA has just approved ARNA weight loss ...

Follow

Get every new post delivered to your Inbox

Join other followers